Human chorionic gonadotropin (hCG) is produced by trophoblastic tissue and it appears around the 8-9th day after ovulation where fertilization has occurred, or around the 4th day after conception.

In a 28 day cycle with ovulation occurring at day 14, hCG can be detected in urine or serum in minute quantities around day 23, or 5 days before the expected menstruation. Its function includes facilitation of implantation as well as maintenance and development of the corpus luteum.

The hormone concentration doubles approximately every 2 days and peaks between concentration of 50,000 mIU/ml. Concentrations as high as 100,000 mIU/ normal subjects, hCG in urine provides an early indication of pregnancy.

One-step hCG Pregnancy Test

Intended Use
The One-step Pregnancy Test is a qualitative colloidal gold/antibody based immunoassay for rapid detection of human Chorionic Gonadotropin (hCG) in urine or serum samples. The test has a sensitivity of 25mIU/ml, making it an effective aid in the early detection of pregnancy.

Human chorionic gonadotropin (hCG) is produced by trophoblastic tissue and it appears around the 8-9th day after ovulation where fertilization has occurred, or around the 4th day after conception.

In a 28 day cycle with ovulation occurring at day 14, hCG can be detected in urine or serum in minute quantities around day 23, or 5 days before the expected menstruation. Its function includes facilitation of implantation as well as maintenance and development of the corpus luteum.

The hormone concentration doubles approximately every 2 days and peaks between concentration of 50,000 mIU/ml. Concentrations as high as 100,000 mIU/ normal subjects, hCG in urine provides an early indication of pregnancy.

One-step hCG Pregnancy Test

Intended Use
The One-step Pregnancy Test is a qualitative colloidal gold/antibody based immunoassay for rapid detection of human Chorionic Gonadotropin (hCG) in urine or serum samples. The test has a sensitivity of 25mIU/ml, making it an effective aid in the early detection of pregnancy.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Intended Use
The Rapid Drugs of Abuse Test is designed for qualitative competitive binding immunoassay for detection of drug substances in human urine specimens. This assay is an easy, quick visually read screening method without the help of instrument and is for use by Professionals only.

Syphilis is a sexually transmitted infection caused by the spirochete bacterium Treponema pallidum subspecies pallidum.

The primary route of transmission is through sexual contact; it may also be transmitted from mother to fetus during pregnancy or at birth, resulting in congenital syphilis. Syphilis is believed to have infected 12 million people worldwide in 1999, with greater than 90% of cases in the developing world. After decreasing dramatically since the widespread availability of penicillin in the 1940s, rates of infection have increased since the turn of the millennium in many countries, often in combination with human immunodeficiency virus (HIV).

This has been attributed partly to unsafe sexual practices among men who have sex with men, increased promiscuity, prostitution, and decreasing use of barrier protection.

Intended Use
The Syphilis test is a chromatographic immunoassay for the detection of all antibodies, including IgM, IgG and IgA to T. pallidum in serum, plasma or whole blood. The test is intended for use by professionals only.